<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37109328</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Use of First-Line Oral Analgesics during and after COVID-19: Results from a Survey on a Sample of Italian 696 COVID-19 Survivors with Post-Acute Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12082992</ELocationID><Abstract><AbstractText>Background-Analgesics could be used to manage painful symptoms during and after COVID-19. Materials and methods-Persistence of painful symptoms was assessed during and after COVID-19 in a sample of patients admitted to a post-acute COVID-19 outpatient service in Rome, Italy. Data on type and frequency of use of first-line analgesics were collected. Pain severity was evaluated with a numeric rating scale (NRS) from 0 to 10. Results-Mean age of 696 participants was 57.1 &#xb1; 20.3 years and 61.7% were women. During COVID-19, the most prevalent symptoms were fever, fatigue, arthralgia, myalgia and headache. Acetaminophen was used by 40% of the sample. Only 6.7% needed to continue analgesic therapy after COVID-19. Frequent causes of analgesics consumption were persistent arthralgia and myalgia. The most common analgesics used amongst those who continued taking analgesics in the post-acute phase of COVID-19 were the following: acetaminophen (31%), ibuprofen (31%) and other non-steroidal anti-inflammatory drug (NSAID) (29.5%); in older subjects the most common analgesic used was acetaminophen (54%). Most of the subjects in this group said there was an improvement in pain perception after taking analgesic therapy (84%). Conclusions-Use of analgesics in the post-acute COVID-19 is common in subjects with persistent arthralgia and myalgia, and common analgesics were acetaminophen and ibuprofen. Further research on the safety and efficacy of those medications in COVID-19 is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galluzzo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4620-5979</Identifier><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zazzara</LastName><ForeName>Maria Beatrice</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciciarello</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5750-9746</Identifier><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bizzarro</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paglionico</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varriano</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gremese</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5472-2365</Identifier><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics and Orthopedics, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics and Orthopedics, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Gemelli against COVID-19 Post-Acute Care Team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NSAIDs</Keyword><Keyword MajorTopicYN="N">acetaminophen</Keyword><Keyword MajorTopicYN="N">arthralgia</Keyword><Keyword MajorTopicYN="N">geriatrics</Keyword><Keyword MajorTopicYN="N">headache</Keyword><Keyword MajorTopicYN="N">ibuprofen</Keyword><Keyword MajorTopicYN="N">joint pain</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgia</Keyword></KeywordList><CoiStatement>None of the participants in the Gemelli Against COVID-19 Post-Acute Care Study Group has any conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37109328</ArticleId><ArticleId IdType="pmc">PMC10142362</ArticleId><ArticleId IdType="doi">10.3390/jcm12082992</ArticleId><ArticleId IdType="pii">jcm12082992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pascarella G., Strumia A., Piliego C., Bruno F., Del Buono R., Costa F., Scarlata S., Agr&#xf2; F.E. COVID-19 diagnosis and management: A comprehensive review. J. Intern. Med. 2020;288:192&#x2013;206. doi: 10.1111/joim.13091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13091</ArticleId><ArticleId IdType="pmc">PMC7267177</ArticleId><ArticleId IdType="pubmed">32348588</ArticleId></ArticleIdList></Reference><Reference><Citation>Vad&#xe1;sz I., Husain-Syed F., Dorfm&#xfc;ller P., Roller F.C., Tello K., Hecker M., E Morty R., Gattenl&#xf6;hner S., Walmrath H.-D., Grimminger F., et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76:201&#x2013;204. doi: 10.1136/thoraxjnl-2020-216088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216088</ArticleId><ArticleId IdType="pubmed">33177230</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway A.H., Scheraga R.G., Bhimraj A., Biehl M., Hatipo&#x11f;lu U. Severe COVID-19 pneumonia: Pathogenesis and clinical management. BMJ. 2021;372:n436. doi: 10.1136/bmj.n436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n436</ArticleId><ArticleId IdType="pubmed">33692022</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad. Med. J. 2020;97:312&#x2013;320. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group Post-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin. Exp. Res. 2020;32:1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Post COVID-19 Condition (Long COVID)  [(accessed on 7 December 2022)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra N., Grill M.F., Singh R.B.H. Post-COVID Headache: A Literature Review. Curr. Pain Headache Rep. 2022;26:835&#x2013;842. doi: 10.1007/s11916-022-01086-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01086-y</ArticleId><ArticleId IdType="pmc">PMC9533267</ArticleId><ArticleId IdType="pubmed">36197571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K., G&#xe1;lvez N.M.S., R&#xed;os M., Kalergis A.M. Neurologic Alterations Due to Respiratory Virus Infections. Front. Cell. Neurosci. 2018;12:386. doi: 10.3389/fncel.2018.00386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Cui H., Wang T., Shen X., Ma C. Pain: A potential new label of COVID-19. Brain Behav. Immun. 2020;87:159&#x2013;160. doi: 10.1016/j.bbi.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7204693</ArticleId><ArticleId IdType="pubmed">32389704</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.-J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: A literature review. J. Clin. Neurosci. 2020;77:8&#x2013;12. doi: 10.1016/j.jocn.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7200361</ArticleId><ArticleId IdType="pubmed">32409215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala K., Martens J., Abd-Elsayed A. Post-COVID Pain Syndromes. Curr. Pain Headache Rep. 2022;26:379&#x2013;383. doi: 10.1007/s11916-022-01038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01038-6</ArticleId><ArticleId IdType="pmc">PMC8907389</ArticleId><ArticleId IdType="pubmed">35267156</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaechi O., Human M.M., Featherstone K. Pharmacologic Therapy for Acute Pain. Am. Fam. Physician. 2021;104:63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">34264611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner P., McCarberg B.H., Grange L., Kolosov A., Haveric A.L., Zucal V., Petruschke R., Bissonnette S. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim. Care Respir. Med. 2022;32:35. doi: 10.1038/s41533-022-00300-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-022-00300-z</ArticleId><ArticleId IdType="pmc">PMC9489480</ArticleId><ArticleId IdType="pubmed">36127354</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.R., Derry S., Wiffen P.J., Straube S., Bendtsen L. Evidence for efficacy of acute treatment of episodic tension-type headache: Methodological critique of randomised trials for oral treatments. Pain. 2014;155:2220&#x2013;2228. doi: 10.1016/j.pain.2014.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2014.08.009</ArticleId><ArticleId IdType="pubmed">25139586</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbie R., Derry S., Moore R.A. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst. Rev. 2013;2019:CD008039. doi: 10.1002/14651858.CD008039.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008039.pub3</ArticleId><ArticleId IdType="pmc">PMC6457976</ArticleId><ArticleId IdType="pubmed">23633348</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore R., Derry S., Wiffen P., Straube S., Aldington D. Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. Eur. J. Pain. 2015;19:1213&#x2013;1223. doi: 10.1002/ejp.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.649</ArticleId><ArticleId IdType="pubmed">25530283</ArticleId></ArticleIdList></Reference><Reference><Citation>Derry S., Moore R.A. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst. Rev. 2013;2019:CD008040. doi: 10.1002/14651858.CD008040.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008040.pub3</ArticleId><ArticleId IdType="pmc">PMC6483792</ArticleId><ArticleId IdType="pubmed">23633349</ArticleId></ArticleIdList></Reference><Reference><Citation>Towheed T., Maxwell L., Judd M., Catton M., Hochberg M.C., Wells G.A. Acetaminophen for osteoarthritis. Cochrane Database Syst. Rev. 2006;2006:CD004257. doi: 10.1002/14651858.CD004257.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004257.pub2</ArticleId><ArticleId IdType="pmc">PMC8275921</ArticleId><ArticleId IdType="pubmed">16437479</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.R., Eccleston C., Derry S., Wiffen P., Bell R.F., Straube S., McQuay H. &#x201c;Evidence&#x201d; in chronic pain&#x2014;Establishing best practice in the reporting of systematic reviews. Pain. 2010;150:386&#x2013;389. doi: 10.1016/j.pain.2010.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2010.05.011</ArticleId><ArticleId IdType="pubmed">20627575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R.M., Stefano G.B. Long-Term Respiratory and Neurological Sequelae of COVID-19. Experiment. 2020;26:e928996-1. doi: 10.12659/MSM.928996.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A., Gheibi Hayat S.M., Taghizadeh H., Akbari A., Inabadi M., Savardashtaki A., Johnston T.P., Sahebkar A. COVID-19 and cardiac injury: Clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev. Anti. Infect. Ther. 2021;19:345&#x2013;357. doi: 10.1080/14787210.2020.1822737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1822737</ArticleId><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M., et al. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo V., Ciciarello F., Tosato M., Zazzara M.B., Pais C., Savera G., Calvani R., Picca A., Marzetti E., Landi F. Association between vitamin D status and physical performance in COVID-19 survivors: Results from the Gemelli against COVID-19 post-acute care project. Mech. Ageing Dev. 2022;205:111684. doi: 10.1016/j.mad.2022.111684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111684</ArticleId><ArticleId IdType="pmc">PMC9093083</ArticleId><ArticleId IdType="pubmed">35568146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautenbacher S., Peters J.H., Heesen M., Scheel J., Kunz M. Age changes in pain perception: A systematic-review and meta-analysis of age effects on pain and tolerance thresholds. Neurosci. Biobehav. Rev. 2017;75:104&#x2013;113. doi: 10.1016/j.neubiorev.2017.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.039</ArticleId><ArticleId IdType="pubmed">28159611</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Navarro-Santana M.P., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L.D.M. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Calvani R., Picca A., Ciciarello F., Galluzzo V., Coelho-J&#xfa;nior H.J., Di Giorgio A., Di Mario C., Gervasoni J., Gremese E., et al. Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>VGalluzzo V., Zazzara M.B., Ciciarello F., Savera G., Pais C., Calvani R., Picca A., Marzetti E., Landi F., Tosato M., et al. Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function. Clin. Nutr. ESPEN. 2022;51:215&#x2013;221. doi: 10.1016/j.clnesp.2022.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2022.08.029</ArticleId><ArticleId IdType="pmc">PMC9428328</ArticleId><ArticleId IdType="pubmed">36184207</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., E Hughes S., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra-Silvestre E., Bisset L., Coppieters M.W. Altered pain processing in people with type I and II diabetes: A protocol for a systematic review and meta-analysis of pain threshold and pain modulation mechanisms. Syst. Rev. 2018;7:222. doi: 10.1186/s13643-018-0895-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-018-0895-2</ArticleId><ArticleId IdType="pmc">PMC6280339</ArticleId><ArticleId IdType="pubmed">30518431</ArticleId></ArticleIdList></Reference><Reference><Citation>Glare P., Aubrey K., Gulati A., Lee Y.C., Moryl N., Overton S. Pharmacologic Management of Persistent Pain in Cancer Survivors. Drugs. 2022;82:275&#x2013;291. doi: 10.1007/s40265-022-01675-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-022-01675-6</ArticleId><ArticleId IdType="pmc">PMC8888381</ArticleId><ArticleId IdType="pubmed">35175587</ArticleId></ArticleIdList></Reference><Reference><Citation>Paice J.A. Pain in Cancer Survivors: How to Manage. Curr. Treat. Options Oncol. 2019;20:48. doi: 10.1007/s11864-019-0647-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11864-019-0647-0</ArticleId><ArticleId IdType="pubmed">31062182</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson C.L., Kim R.S., Li M., Ruan Q.Z., Surapaneni S., Jones M., Pak D.J., Southerland W. The Impact of Smoking on the Development and Severity of Chronic Pain. Curr. Pain Headache Rep. 2022;26:575&#x2013;581. doi: 10.1007/s11916-022-01060-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01060-8</ArticleId><ArticleId IdType="pubmed">35731364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiba J.D., Zale E., Ditre J.W. Associations between pain intensity and urge to smoke: Testing the role of negative affect and pain catastrophizing. Drug Alcohol Depend. 2018;187:100&#x2013;108. doi: 10.1016/j.drugalcdep.2018.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2018.01.037</ArticleId><ArticleId IdType="pmc">PMC5959791</ArticleId><ArticleId IdType="pubmed">29655030</ArticleId></ArticleIdList></Reference><Reference><Citation>A Pierce C., Voss B. Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review. Ann. Pharmacother. 2010;44:489&#x2013;506. doi: 10.1345/aph.1M332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1M332</ArticleId><ArticleId IdType="pubmed">20150507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger K., T&#xf6;pfner N., Berner R., Windfuhr J., Oltrogge J.H. Sore Throat. Dtsch. Arztebl. Int. 2021;118:188&#x2013;194. doi: 10.3238/arztebl.m2021.0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2021.0121</ArticleId><ArticleId IdType="pmc">PMC8245861</ArticleId><ArticleId IdType="pubmed">33602392</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi M., Sayar S., Radmanesh E., Naghshi S., Mousaviasl S., Jelvay S., Ebrahimzadeh M., Mohammadi A., Abbasi S., Mobarak S., et al. Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:102319. doi: 10.1016/j.dsx.2021.102319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102319</ArticleId><ArticleId IdType="pmc">PMC8530771</ArticleId><ArticleId IdType="pubmed">34700294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Huang S., Huang S., Liu F., Shao W., Mei K., Ma J., Jiang Y., Wan J., Zhu W., et al. Prevalence of NSAID use among people with COVID-19 and the association with COVID-19-related outcomes: Systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2022;88:5113&#x2013;5127. doi: 10.1111/bcp.15512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15512</ArticleId><ArticleId IdType="pmc">PMC9538204</ArticleId><ArticleId IdType="pubmed">36029185</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur M., Datusalia A.K., Kumar A. Use of steroids in COVID-19 patients: A meta-analysis. Eur. J. Pharmacol. 2022;914:174579. doi: 10.1016/j.ejphar.2021.174579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174579</ArticleId><ArticleId IdType="pmc">PMC8525014</ArticleId><ArticleId IdType="pubmed">34678244</ArticleId></ArticleIdList></Reference><Reference><Citation>Pergolizzi J.V., Magnusson P., LeQuang J.A., Breve F., Taylor R., Wollmuth C., Varrassi G. Can NSAIDs and Acetaminophen Effectively Replace Opioid Treatment Options for Acute Pain? Expert Opin. Pharmacother. 2021;22:1119&#x2013;1126. doi: 10.1080/14656566.2021.1901885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2021.1901885</ArticleId><ArticleId IdType="pubmed">33689517</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa B.R., Pereira T.V., Saadat P., Rudnicki M., Iskander S.M., Bodmer N.S., Bobos P., Gao L., Kiyomoto H.D., Montezuma T., et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis. BMJ. 2021;375:n2321. doi: 10.1136/bmj.n2321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2321</ArticleId><ArticleId IdType="pmc">PMC8506236</ArticleId><ArticleId IdType="pubmed">34642179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindu S., Mazumder S., Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharmacol. 2020;180:114147. doi: 10.1016/j.bcp.2020.114147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.114147</ArticleId><ArticleId IdType="pmc">PMC7347500</ArticleId><ArticleId IdType="pubmed">32653589</ArticleId></ArticleIdList></Reference><Reference><Citation>Harirforoosh S., Asghar W., Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. J. Pharm. Pharm. Sci. 2014;16:821&#x2013;847. doi: 10.18433/J3VW2F.</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/J3VW2F</ArticleId><ArticleId IdType="pubmed">24393558</ArticleId></ArticleIdList></Reference><Reference><Citation>Arf&#xe8; A., Scotti L., Varas-Lorenzo C., Nicotra F., Zambon A., Kollhorst B., Schink T., Garbe E., Herings R., Straatman H., et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: Nested case-control study. BMJ. 2016;354:i4857. doi: 10.1136/bmj.i4857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4857</ArticleId><ArticleId IdType="pubmed">27682515</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi F., Iacomini P., Marsiliani D., Cordischi C., Antonini E.F.S., Alesi A., Giacobelli D., Zuccal&#xe0; G. Safety and efficacy of the combination acetaminophen-codeine in the treatment of pain of different origin. Eur. Rev. Med. Pharmacol. Sci. 2013;17:2129&#x2013;2135.</Citation><ArticleIdList><ArticleId IdType="pubmed">23893177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>